YCCEL1Homo sapiens (Human)Cancer cell line
Also known as: YCC10, YCC-10
AI Summary
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_9647 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Ascites[UBERON:UBERON_0007795] |
Disease Information
| Disease | Gastric adenocarcinoma |
|---|
DepMap Information
Known Sequence Variations
| Type | Gene/Protein | Description | Zygosity | Note | Source |
|---|---|---|---|---|---|
| MutationSimple | MET | p.His58Leu | Unspecified | - | PubMed=29435981 |
Publications
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
Kragh M., Horak I.D., Chung H.C., Rha S.Y.
Int. J. Cancer 143:151-159(2018).
Highly efficient CRISPR/Cas9-mediated cloning and functional characterization of gastric cancer-derived Epstein-Barr virus strains.
Kanda T., Furuse Y., Oshitani H., Kiyono T.
J. Virol. 90:4383-4393(2016).
Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
Allday M.J., Rickinson A.B., Young L.S., Farrell P.J., Kellam P.
J. Virol. 89:5222-5237(2015).
Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.
Rha S.Y., Lee S.K.
J. Gen. Virol. 94:497-506(2013).
In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Noh S.H., Rha S.Y.
Genomics 93:52-61(2009).
Novel gastric cancer cell lines established from diffuse type gastric cancer patients for potential subgroup-specific therapy.
Kim H.M., Rha S.Y., Chung H.C.
Cancer Res. 76 Suppl. 14:139-139(2016).